vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and VNET Group, Inc. (VNET). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $362.7M, roughly 1.3× VNET Group, Inc.). CLOVER HEALTH INVESTMENTS, CORP. runs the higher net margin — -10.1% vs -10.7%, a 0.6% gap on every dollar of revenue. CLOVER HEALTH INVESTMENTS, CORP. produced more free cash flow last quarter ($-69.0M vs $-193.1M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 17.4%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

VNET Group, Inc. is a leading neutral internet data center service provider operating primarily in China. It offers cloud computing infrastructure, colocation services, managed network solutions, and hybrid cloud support to enterprise clients across technology, finance, and retail sectors, enabling stable, high-performance digital operation foundations for domestic and global businesses expanding in the Chinese market.

CLOV vs VNET — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.3× larger
CLOV
$487.7M
$362.7M
VNET
Higher net margin
CLOV
CLOV
0.6% more per $
CLOV
-10.1%
-10.7%
VNET
More free cash flow
CLOV
CLOV
$124.1M more FCF
CLOV
$-69.0M
$-193.1M
VNET
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
17.4%
VNET

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
CLOV
CLOV
VNET
VNET
Revenue
$487.7M
$362.7M
Net Profit
$-49.3M
$-38.7M
Gross Margin
20.9%
Operating Margin
-10.1%
0.5%
Net Margin
-10.1%
-10.7%
Revenue YoY
44.7%
Net Profit YoY
-123.2%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
VNET
VNET
Q4 25
$487.7M
Q3 25
$496.6M
$362.7M
Q2 25
$477.6M
Q1 25
$462.3M
$309.5M
Q4 24
$337.0M
Q3 24
$331.0M
$302.2M
Q2 24
$356.3M
$274.4M
Q1 24
$346.9M
$262.9M
Net Profit
CLOV
CLOV
VNET
VNET
Q4 25
$-49.3M
Q3 25
$-24.4M
$-38.7M
Q2 25
$-10.6M
Q1 25
$-1.3M
$-2.4M
Q4 24
$-22.1M
Q3 24
$-9.2M
$-2.1M
Q2 24
$7.4M
$-1.1M
Q1 24
$-19.2M
$-22.0M
Gross Margin
CLOV
CLOV
VNET
VNET
Q4 25
Q3 25
20.9%
Q2 25
Q1 25
25.2%
Q4 24
Q3 24
24.5%
23.2%
Q2 24
30.3%
21.3%
Q1 24
23.6%
21.6%
Operating Margin
CLOV
CLOV
VNET
VNET
Q4 25
-10.1%
Q3 25
-4.9%
0.5%
Q2 25
-2.2%
Q1 25
-0.3%
0.1%
Q4 24
-6.4%
Q3 24
-2.7%
24.5%
Q2 24
2.0%
0.2%
Q1 24
-6.5%
0.2%
Net Margin
CLOV
CLOV
VNET
VNET
Q4 25
-10.1%
Q3 25
-4.9%
-10.7%
Q2 25
-2.2%
Q1 25
-0.3%
-0.8%
Q4 24
-6.6%
Q3 24
-2.8%
-0.7%
Q2 24
2.1%
-0.4%
Q1 24
-5.5%
-8.4%

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
VNET
VNET
Cash + ST InvestmentsLiquidity on hand
$78.3M
$492.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$890.8M
Total Assets
$541.0M
$6.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
VNET
VNET
Q4 25
$78.3M
Q3 25
$492.1M
Q2 25
Q1 25
$544.3M
Q4 24
$194.5M
Q3 24
$288.0M
$219.5M
Q2 24
$254.8M
$247.2M
Q1 24
$208.3M
$246.9M
Total Debt
CLOV
CLOV
VNET
VNET
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$1.2B
Q2 24
Q1 24
Stockholders' Equity
CLOV
CLOV
VNET
VNET
Q4 25
$308.7M
Q3 25
$340.9M
$890.8M
Q2 25
$344.2M
Q1 25
$336.1M
$927.8M
Q4 24
$341.1M
Q3 24
$342.2M
$902.9M
Q2 24
$324.9M
$900.6M
Q1 24
$292.5M
$895.1M
Total Assets
CLOV
CLOV
VNET
VNET
Q4 25
$541.0M
Q3 25
$559.7M
$6.1B
Q2 25
$575.0M
Q1 25
$583.7M
$5.4B
Q4 24
$580.7M
Q3 24
$653.0M
$4.3B
Q2 24
$674.2M
$4.0B
Q1 24
$671.8M
$3.9B
Debt / Equity
CLOV
CLOV
VNET
VNET
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
1.28×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
VNET
VNET
Operating Cash FlowLast quarter
$-66.9M
$113.8M
Free Cash FlowOCF − Capex
$-69.0M
$-193.1M
FCF MarginFCF / Revenue
-14.1%
-53.2%
Capex IntensityCapex / Revenue
0.4%
84.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$-589.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
VNET
VNET
Q4 25
$-66.9M
Q3 25
$12.1M
$113.8M
Q2 25
$5.4M
Q1 25
$-16.3M
$27.0M
Q4 24
$34.8M
Q3 24
$50.0M
$108.3M
Q2 24
$44.8M
$55.8M
Q1 24
$25.9M
$37.1M
Free Cash Flow
CLOV
CLOV
VNET
VNET
Q4 25
$-69.0M
Q3 25
$11.4M
$-193.1M
Q2 25
$4.8M
Q1 25
$-16.5M
$-220.0M
Q4 24
$33.3M
Q3 24
$49.6M
$-95.0M
Q2 24
$44.4M
$-81.6M
Q1 24
$25.5M
$-102.2M
FCF Margin
CLOV
CLOV
VNET
VNET
Q4 25
-14.1%
Q3 25
2.3%
-53.2%
Q2 25
1.0%
Q1 25
-3.6%
-71.1%
Q4 24
9.9%
Q3 24
15.0%
-31.4%
Q2 24
12.5%
-29.8%
Q1 24
7.3%
-38.9%
Capex Intensity
CLOV
CLOV
VNET
VNET
Q4 25
0.4%
Q3 25
0.1%
84.6%
Q2 25
0.1%
Q1 25
0.0%
79.8%
Q4 24
0.5%
Q3 24
0.1%
67.3%
Q2 24
0.1%
50.1%
Q1 24
0.1%
53.0%
Cash Conversion
CLOV
CLOV
VNET
VNET
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
6.04×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons